TearClear: A Novel Means of Making Ophthalmic Solutions Preservative Free

article image
ARTICLE SUMMARY:

Preservatives in multi-dose eye-drop prescriptions used to treat glaucoma and other eye disorders put patients at risk of a range of serious adverse reactions. Early-stage start-up TearClear believes it has come up with a safe and economically feasible way to solve this problem and bring preservative-free eye drops to a wider patient population.

Preservatives are a common ingredient in multi-dose eye-drop prescriptions used to treat glaucoma and other eye disorders.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.


Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite

Questions?

We're here to help! Please contact us at: